Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Otx2 ELISA Kit (AC3163)
Cat.#: ASET-1752
Specifications
Description Human Otx2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Otx2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 10.06 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2344 Human CysLT1 ELISA Kit (AC3755) Quantitative inquiry ASET-1026 Human Cadherin 8 ELISA Kit (AC2437) Quantitative inquiry ASET-1917 Human Leptin ELISA Kit (AC3328) Quantitative inquiry ASET-2516 Mouse alpha B Crystallin ELISA Kit (AC3927) Quantitative inquiry ASET-1744 Human Oligodendrocyte Specific Protein ELISA Kit (AC3155) Quantitative inquiry ASET-1028 Mouse FGF1 ELISA Kit (AC2439) Quantitative inquiry ASET-1523 Human Glicentin ELISA Kit (AC2934) Quantitative inquiry ASET-1945 Human ZnT1 ELISA Kit (AC3356) Quantitative inquiry ASET-1673 Mouse NKCC1 ELISA Kit (AC3084) Quantitative inquiry ASET-1631 Rabbit eNOS ELISA Kit (AC3042) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket